SAFETY AND EFFICACY OF IV S-ADENOSYL-L-METHIONINE (SAME SD4*) IN CIRRHOSIS
SAFETY AND EFFICACY OF IV S-ADENOSYL-L-METHIONINE (SAME SD4*) IN CIRRHOSIS
批准号:
6281820
负责人:
R K CHAWLA
金额:
$3.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30
关键词:
S adenosylmethionine bilirubin blood chemistry cholestasis clearance rate clinical research galactose human subject human therapy evaluation intravenous administration liver cirrhosis liver disorder chemotherapy liver function oral administration transaminases tumor necrosis factor alpha unsaturated fatty acids
中文摘要
确定每天静脉输注该药物是否会改善
稳定期肝硬变患者肝功能/生化指标的变化
胆汁淤积症患者口服黄连素的血浆清除率
麦硫宁。血清肝转氨酶和游离胆红素水平。
血浆和红细胞PC的多不饱和脂肪酸含量。谷胱甘肽
血浆和红细胞水平。肝半乳糖清除
容量。安替比林清除。血浆肿瘤坏死因子,体外,体外肿瘤坏死因子和
单核细胞肿瘤坏死因子。单核细胞肿瘤坏死因子基因的表达。
英文摘要
Determine whether a daily intraveous infusion of SAMe will improve the
following hepatic functions/biochemical indices in stable cirrhotic
patients with cholestasis: Rate of plasma clearance of an oral bolus of
mtehionine. Serum levels of liver transaminases and free bilirubin.
Polyunsaturated fatty acid contents of plasma and erythrocyte PC. GSH
levels of plasma and erythrocyte. Hepatic galactose elimination
capacity.Antipyrine clearance. Plasma TNf, ex-vivo, ex vivo TNF and
monocyte TNF. MRNA of monocyte TNF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY AND EFFICACY OF IV S-ADENOSYL-L-METHIONINE (SAME SD4*) IN CIRRHOSIS
-
批准号:6252386
-
项目类别:
-
资助金额:$2.92万
-
财政年份:1997
-
负责人:R K CHAWLA
-
依托单位:
SAFETY AND EFFICACY OF IV S-ADENOSYL-L-METHIONINE (SAME SD4*) IN CIRRHOSIS
-
批准号:5224262
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:R K CHAWLA
-
依托单位:--
SAFETY AND EFFICACY OF IV S-ADENOSYL-L-METHIONINE (SAME SD4*) IN CIRRHOSIS
-
批准号:6121280
-
项目类别:
-
资助金额:$3.21万
-
财政年份:--
-
负责人:R K CHAWLA
-
依托单位:
海外基金